Health Affairs: How The U.S. Elevates Corporate Interests Over Global Public Health. And How The World Can Respond
Lawrence O. Gostin, O’Neill professor of global health law and director of the World Health Organization Collaborating Center on National and Global Health Law at Georgetown University; Neil R. Sircar, Fogarty global health fellow and human rights lawyer affiliated with Georgetown University Law Center and the O’Neill Institute for National and Global Health Law; and Eric A. Friedman, institute associate and project leader for the Platform for a Framework Convention on Global Health (FCGH) at the O’Neill Institute

“…[I]t is not just through the aggressive elevation of corporate interests that the [Trump] administration is undermining international norms developed over generations. Such efforts are but one piece of its broader disregard for international cooperation to resolve global health, environmental, security, and other threats. … [S]olidarity and resistance … should form the international response to U.S. efforts that promote industry interests over public health, that disregard global norms aimed at promoting health and human rights, that seek to undermine global institutions, and that dismiss solid science. … And international negotiators should be willing to break with norms of consensus if that is what is necessary for health and human rights to win out. It may not always be possible for countries to stand up to the United States, particularly in bilateral negotiations, but wherever possible, that should be the international community’s approach. There will come a time when the U.S. returns to the international fold. Until then, the administration should be shown that bullying will not work” (9/5).